Please assess the completion status of the following clinical trial:

Trial Title: Chondromodulating Effect of Diacerein in Osteoarthritis of the Hip

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Outpatients fulfilling the American College of Rheumatology criteria for the diagnosis of hip osteoarthritis.~* Lequesne algofunctional index of at list 3 points.~* Radiographic criterion for inclusion: joint space width (JSW) between 1 mm and 3 mm. If the JSW exceeded 3 mm, it had to be at least 0.5 mm thinner than JSW of the contra lateral hip, measured at its narrowest point.~Exclusion Criteria:~* Intraarticular injection or arthroscopy of the hip during the three months prior to inclusion in the study.~* Any systemic or intraarticular corticosteroid as well as other potential symptom-modifying drugs for osteoarthritis were not allowed during the study.

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).